Synlogic (SYBX) Competitors $1.40 -0.10 (-6.67%) Closing price 08/5/2025 04:00 PM EasternExtended Trading$1.52 +0.13 (+8.93%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SYBX vs. ARTV, QNTM, ATRA, STRO, ASRT, PYXS, INCR, OTLK, VNRX, and RPTXShould you be buying Synlogic stock or one of its competitors? The main competitors of Synlogic include Artiva Biotherapeutics (ARTV), Quantum Biopharma (QNTM), Atara Biotherapeutics (ATRA), Sutro Biopharma (STRO), Assertio (ASRT), Pyxis Oncology (PYXS), InterCure (INCR), Oncobiologics (OTLK), VolitionRx (VNRX), and Repare Therapeutics (RPTX). These companies are all part of the "pharmaceutical products" industry. Synlogic vs. Its Competitors Artiva Biotherapeutics Quantum Biopharma Atara Biotherapeutics Sutro Biopharma Assertio Pyxis Oncology InterCure Oncobiologics VolitionRx Repare Therapeutics Artiva Biotherapeutics (NASDAQ:ARTV) and Synlogic (NASDAQ:SYBX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, analyst recommendations, institutional ownership and risk. Is ARTV or SYBX more profitable? Synlogic's return on equity of 10.91% beat Artiva Biotherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Artiva BiotherapeuticsN/A -75.95% -39.51% Synlogic N/A 10.91%7.47% Which has higher valuation & earnings, ARTV or SYBX? Synlogic has lower revenue, but higher earnings than Artiva Biotherapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArtiva Biotherapeutics$250K300.12-$65.37MN/AN/ASynlogic$10K1,638.00-$23.36M-$2.51-0.56 Does the media prefer ARTV or SYBX? In the previous week, Artiva Biotherapeutics had 2 more articles in the media than Synlogic. MarketBeat recorded 2 mentions for Artiva Biotherapeutics and 0 mentions for Synlogic. Artiva Biotherapeutics' average media sentiment score of 0.00 equaled Synlogic'saverage media sentiment score. Company Overall Sentiment Artiva Biotherapeutics Neutral Synlogic Neutral Do analysts recommend ARTV or SYBX? Artiva Biotherapeutics currently has a consensus target price of $17.80, suggesting a potential upside of 477.92%. Given Artiva Biotherapeutics' stronger consensus rating and higher possible upside, research analysts clearly believe Artiva Biotherapeutics is more favorable than Synlogic.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Artiva Biotherapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Synlogic 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals hold more shares of ARTV or SYBX? 63.4% of Synlogic shares are held by institutional investors. 21.4% of Artiva Biotherapeutics shares are held by company insiders. Comparatively, 3.0% of Synlogic shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryArtiva Biotherapeutics beats Synlogic on 6 of the 11 factors compared between the two stocks. Get Synlogic News Delivered to You Automatically Sign up to receive the latest news and ratings for SYBX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SYBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SYBX vs. The Competition Export to ExcelMetricSynlogicMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.54M$3.07B$5.59B$9.53BDividend YieldN/A2.41%4.71%4.14%P/E Ratio-0.5617.5328.8923.88Price / Sales1,638.00313.17447.6498.82Price / CashN/A42.6035.6858.35Price / Book1.287.828.165.60Net Income-$23.36M-$54.52M$3.25B$265.26M7 Day Performance-7.89%2.86%1.12%-0.15%1 Month Performance17.06%17.29%8.22%6.07%1 Year Performance-16.67%13.27%29.12%24.21% Synlogic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SYBXSynlogic1.0148 of 5 stars$1.40-6.7%N/A-11.9%$17.54M$10K-0.5680Gap DownARTVArtiva Biotherapeutics2.138 of 5 stars$3.01+6.4%$17.80+491.4%-72.3%$68.95M$250K0.0081Upcoming EarningsQNTMQuantum BiopharmaN/A$27.80+17.3%N/AN/A$68.91MN/A-1.74N/ANews CoverageUpcoming EarningsGap DownATRAAtara Biotherapeutics3.8342 of 5 stars$11.32-2.0%$20.00+76.7%+37.3%$68.85M$128.94M-3.04330News CoverageUpcoming EarningsGap UpSTROSutro Biopharma3.8683 of 5 stars$0.83+2.1%$6.11+639.2%-75.2%$68.41M$62.04M-0.28240News CoverageUpcoming EarningsASRTAssertio1.8615 of 5 stars$0.72+1.1%$2.63+264.5%-39.2%$68.24M$124.96M-2.2520News CoveragePYXSPyxis Oncology2.4716 of 5 stars$1.10flat$9.00+718.2%-66.8%$68.14MN/A-0.6960News CoverageUpcoming EarningsINCRInterCureN/A$1.50+4.2%N/A-20.1%$65.62M$238.85M0.00350Gap UpOTLKOncobiologics2.5155 of 5 stars$2.01+4.1%$9.60+377.6%-71.6%$64.79MN/A-2.2120News CoverageUpcoming EarningsVNRXVolitionRx1.4912 of 5 stars$0.62-2.7%$3.50+461.8%+12.3%$64.78M$1.31M-1.7380Gap UpRPTXRepare Therapeutics2.7604 of 5 stars$1.52+1.3%$4.50+196.1%-50.6%$64.34M$53.48M-0.50180 Related Companies and Tools Related Companies Artiva Biotherapeutics Competitors Quantum Biopharma Competitors Atara Biotherapeutics Competitors Sutro Biopharma Competitors Assertio Competitors Pyxis Oncology Competitors InterCure Competitors Oncobiologics Competitors VolitionRx Competitors Repare Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SYBX) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synlogic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Synlogic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
